By Sahil Pandey And Joymala Bagchi

New Delhi [India], December 7 (ANI): Bharat Biotech on Monday applied for emergency use authorisation for its indigenously developed COVID-19 vaccine 'Covaxin' to Drugs Controller General of India (DCGI), officials said.

Also Read | Bharat Bandh Tomorrow: Delhi Police Warn of Strict Action Against Those Disrupting Movement on Nationwide Shutdown.

"Bharat Biotech has sought emergency use authorisation for its indigenously developed COVID-19 vaccine Covaxin from DCGI," a senior government official told to ANI.

Bharat Biotech is the third company which has applied for emergency use authorisation for its vaccine.

Also Read | COVID-19 Vaccine Latest Update: DCGI to Review Data of Covaxin, Covishield and BNT162b2 on December 9, Says Report.

It is the second Indian company to apply for emergency use authorisation after the Serum Institute of India applied for such use for a vaccine developed by Oxford University and AstraZeneca.

Pfizer had applied for the emergency use authorisation to DCGI on December 6.

Pfizer India's parent company Pfizer has already got emergency-use clearance in the United Kingdom and Bahrain. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)